SCHEMBL9214327

SCHEMBL9214327

CCCCOC(=O)N1CCOC(COc2ccc3c(C)c(C(C)C)c(=O)oc3c2C)C1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.43
▸ ALDH1A1 P00352 7/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ HPGD P15428 6/20 0.39
▸ HSD17B10 Q99714 5/20 0.39
▸ TSHR P16473 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9214012 0.86 KDM4E (0.45) KDM4EALDH1A1SMN1; SMN2KMT2AHPGD
SCHEMBL9211090 0.77 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2KMT2AHPGD
SCHEMBL9221753 0.77 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2KMT2AHPGD
SCHEMBL9209696 0.73 HTR2A (0.47) KDM4EALDH1A1SMN1; SMN2KMT2AHPGD
SCHEMBL9211866 0.71 KDM4E (0.52) KDM4EALDH1A1SMN1; SMN2KMT2AHPGD
Fumaric Acid SCHEMBL9209066 0.71 HTR2A (0.41) KDM4EALDH1A1SMN1; SMN2KMT2AHPGD
SCHEMBL9213959 0.71 EPHA2 (0.48) KDM4EALDH1A1KMT2AHPGDHSD17B10
Hydrochloric Acid SCHEMBL9217598 0.71 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2KMT2AHPGD
SCHEMBL29483703 0.69 IRAK4 (0.41) SMN1; SMN2
SCHEMBL30589849 0.68 HRH3 (0.62) KMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0411912-B1 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders SANKYO CO (JP) 1995-04-19 — — EP disclosed
EP-0411912-A2 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders Sankyo Company Limited (JP) 1991-02-06 — — EP disclosed
Send feedback